Skip to main content

Lupus

      RT @Janetbirdope: #Top #EULAR learnings #SLE #recommendations 1 Limit #prednisone 2 use #biologics early if poor progno

      Janet Pope Janetbirdope

      2 years ago
      #Top #EULAR learnings #SLE #recommendations 1 Limit #prednisone 2 use #biologics early if poor prognosis 3 #lupus #nephritis - treat early with #belimumab or #voclosporin and more Rx in #RCTs #gamechanger https://t.co/JHQHu91tud
      Promising new therapies in SLE

      Dr. Yuz Yusof ( @Yuz6Yusof ) weighs in.

      The pharmacology treatment in SLE is a rapidly

      Dr. John Cush RheumNow

      2 years ago
      Promising new therapies in SLE Dr. Yuz Yusof ( @Yuz6Yusof ) weighs in. The pharmacology treatment in SLE is a rapidly expanding field of research that provides excitement and optimism to both the patients and the clinicians. https://t.co/cdVw771HDs https://t.co/OYcN8hFLcP
      Upadacitinib in SLE
      Unmasking Lupus Pregnancy: Adherence and Drug Monitoring Dilemmas

      Preliminary data from a lupus pregnancy LEGACY cohor

      Dr. John Cush RheumNow

      2 years ago
      Unmasking Lupus Pregnancy: Adherence and Drug Monitoring Dilemmas Preliminary data from a lupus pregnancy LEGACY cohort presented at #EULAR23 are alarming. Dr. Bella Mehta ( @bella_mehta ) shares more. https://t.co/cY2G4s4yR0 https://t.co/isepEb8OXD
      The future of lupus treatment is oral therapies?

      There has been an explosion of trials in SLE, including nonrenal and

      Dr. John Cush RheumNow

      2 years ago
      The future of lupus treatment is oral therapies? There has been an explosion of trials in SLE, including nonrenal and glomerulonephritis studies. @Janetbirdope https://t.co/IQ9bxbTSV4 https://t.co/jVYOphxpAE
      RT @drdavidliew: Wasn’t following the SLE stuff #EULAR2023 but heard a lot of talk about both telitacicept & CAR-T

      David Liew drdavidliew

      2 years ago
      Wasn’t following the SLE stuff #EULAR2023 but heard a lot of talk about both telitacicept & CAR-T, including meeting highlights by Christian Dejaco. Both look pretty exciting - the longer the sustained remission with CAR-T, the more it looks like maybe the real deal @RheumNow https://t.co/oKzb8ojTcz
      RT @Yuz6Yusof: #EULAR2023 #POS1156 Previous case series reported ~9% de novo nephritis in #SLE pts treated with belimuma

      Md Yuzaiful Md Yusof Yuz6Yusof

      2 years ago
      #EULAR2023 #POS1156 Previous case series reported ~9% de novo nephritis in #SLE pts treated with belimumab for non-renal lupus. Post-hoc analysis of 5 BEL Non-LN RCTs showed 8% had de novo LN. Risk increased in Asians but lowered with low dose BEL or s/c form @RheumNow https://t.co/GqAr3tppWh
      RT @drdavidliew: New 2023 @eular_org SLE recommendations

      Key changes, in response to evidence:
      - more caution re: stero

      David Liew drdavidliew

      2 years ago
      New 2023 @eular_org SLE recommendations Key changes, in response to evidence: - more caution re: steroids - biologics earlier - combo therapy (BEL or CNI/VCS) considered for lupus nephritis #EULAR2023 @RheumNow https://t.co/J3Lp8owRyT
      RT @Janetbirdope: #ClinicalPearl This is cool - think of SGLT2 for #lupus #nephritis? presented at #SLE recommendations

      Janet Pope Janetbirdope

      2 years ago
      #ClinicalPearl This is cool - think of SGLT2 for #lupus #nephritis? presented at #SLE recommendations ⁦@RheumNow⁩ #EULAR2023 ⁦@eular_org⁩ https://t.co/8mbNt2n64v
      ×